BIOMAT Database Logo BIOMAT Database Logo

Cerebrospinal fluid thyrotropin-releasing hormone concentrations in alcoholics and normal controls. 1990

A Roy, and G Bissette, and C B Nemeroff, and J DeJong, and B Ravitz, and B Adinoff, and M Linnoila
Laboratory of Clinical Studies, DICBR, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.

Alterations in hypothalamic-pituitary-thyroid axis function have been reported in alcoholism. Blunting of the thyroid-stimulating hormone (TSH) response to thyrotropin-releasing hormone (TRH) occurs in approximately 25% of alcoholic patients. Using a sensitive radioimmunoassay that allows TRH itself to be measured in cerebrospinal fluid (CSF), CSF concentrations of TRH were measured in alcoholics and normal controls. There was no significant difference in TRH concentrations between the groups. However, among the controls there was a significant correlation between CSF concentrations of the major serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) and CSF concentrations of TRH. This correlation was lacking in the alcoholics. These findings are of interest because basic neurobiological studies have reported that TRH and serotonin are co-localized in certain neurons in the rat central nervous system.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006897 Hydroxyindoleacetic Acid 5-HIAA,5-Hydroxy-3-Indoleacetic Acid,5-Hydroxyindolamine Acetic Acid,5 Hydroxy 3 Indoleacetic Acid,5 Hydroxyindolamine Acetic Acid,Acetic Acid, 5-Hydroxyindolamine,Acid, 5-Hydroxy-3-Indoleacetic,Acid, 5-Hydroxyindolamine Acetic,Acid, Hydroxyindoleacetic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol
D013961 Thyroid Gland A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively. Thyroid,Gland, Thyroid,Glands, Thyroid,Thyroid Glands,Thyroids

Related Publications

A Roy, and G Bissette, and C B Nemeroff, and J DeJong, and B Ravitz, and B Adinoff, and M Linnoila
Cerebrospinal fluid thyrotropin-releasing hormone concentrations in patients with anxiety disorders.
January 1993, The Journal of neuropsychiatry and clinical neurosciences,
A Roy, and G Bissette, and C B Nemeroff, and J DeJong, and B Ravitz, and B Adinoff, and M Linnoila
Thyrotropin-releasing hormone test in recently abstinent alcoholics.
November 1985, Psychiatry research,
A Roy, and G Bissette, and C B Nemeroff, and J DeJong, and B Ravitz, and B Adinoff, and M Linnoila
Thyrotropin releasing hormone levels in human cerebrospinal fluid in various neurologic diseases.
March 1986, The American journal of the medical sciences,
A Roy, and G Bissette, and C B Nemeroff, and J DeJong, and B Ravitz, and B Adinoff, and M Linnoila
Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls.
September 1995, Biological psychiatry,
A Roy, and G Bissette, and C B Nemeroff, and J DeJong, and B Ravitz, and B Adinoff, and M Linnoila
Carbamazepine increases cerebrospinal fluid thyrotropin-releasing hormone levels in affectively ill patients.
August 1994, Archives of general psychiatry,
A Roy, and G Bissette, and C B Nemeroff, and J DeJong, and B Ravitz, and B Adinoff, and M Linnoila
Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.
August 1997, Biological psychiatry,
A Roy, and G Bissette, and C B Nemeroff, and J DeJong, and B Ravitz, and B Adinoff, and M Linnoila
Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
June 1992, The Journal of clinical endocrinology and metabolism,
A Roy, and G Bissette, and C B Nemeroff, and J DeJong, and B Ravitz, and B Adinoff, and M Linnoila
Thyrotropin response to thyrotropin releasing hormone in normal subjects.
February 1974, European journal of clinical investigation,
A Roy, and G Bissette, and C B Nemeroff, and J DeJong, and B Ravitz, and B Adinoff, and M Linnoila
Transport of thyrotropin-releasing hormone from cerebrospinal fluid to hypophysial portal blood and the release of thyrotropin.
November 1975, Endocrinology,
A Roy, and G Bissette, and C B Nemeroff, and J DeJong, and B Ravitz, and B Adinoff, and M Linnoila
Low-dose thyrotropin-releasing hormone effects in cognitively impaired alcoholics.
August 1993, Alcoholism, clinical and experimental research,
Copied contents to your clipboard!